number of downloads : ?
language
eng
Author
Shigematsu Takashi Department of Nephrology, Wakayama Medical University, 811-1 Kimiidera, Wakayama-City, Wakayama, 641-8509, Japan
Muraoka Ryoichi Data Science Group, Clinical Development Department, EA Pharma Co., Ltd, Tokyo, Japan
Nishizawa Yoshiki Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan
Subject
Chronic kidney disease (CKD); Bone disease; Osteoporosis; Biomarkers; Calcium; Treatment
Journal Title
BMC NEPHROLOGY
Volume
18
ISSN
1471-2369
Published Date
2017-02-15
DOI
PubMed ID
Publisher
BIOMED CENTRAL LTD
NII Type
Journal Article
OAI-PMH Set
Faculty of Medicine
Remark
This study was supported by the Joint Development Program of EA Pharma Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Funding for writing/editorial support was provided by EA Pharma Co., Ltd.